Sisram Medical Ltd (HK:1696), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced on Tuesday the official launch of its Titanium Prime treatment concept in Hong Kong SAR.
Integrating two flagship EBD platforms, Alma PrimeX and Soprano Titanium Special Edition, the new concept expands the range of combined aesthetic solutions available locally and accelerates Sisram's strategic shift toward an integrated, multi-technology service delivery model.
Powered by Tri-Energy Synergy technology, Titanium Prime unites laser, radiofrequency, and ultrasound modalities via the exclusive BTS2 Methodology, a layered system engineered to target varying tissue depths and deliver multidimensional anti-ageing and skin rejuvenation outcomes. It leverages the complementary technical strengths of Alma PrimeX and Soprano Titanium Special Edition to focus on multi-layered tissue care spanning the epidermis, dermis, and subcutaneous layers. This approach helps to complement the diverse aesthetic needs of patients, including skin texture, firmness, and facial contours, Sisram said.
The rollout in Hong Kong SAR is expected to serve as a benchmark for tailoring localised combined treatment strategies across key APAC markets.
Frontier IP portfolio company InSignals wins EU grant and launches Parkinson's app
PharmaResearch to acquire CG USA to support North American expansion of REJURAN Cosmetics
United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device
Natera Signatera gains PMDA approval in Japan for colorectal cancer testing
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
Medtronic seeks expanded US approvals for Hugo robotic surgery system
Waters secures FDA clearance for BD BACTEC FXI Blood Culture System
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
ILC Dover adds Water for Injection (WFI) and custom chemical solutions to offerings
Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China
Implantica submits final FDA response for RefluxStop PMA application
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer